BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 1151941)

  • 21. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
    Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
    Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transition of benign vaginal adenosis to clear cell carcinoma.
    Ghosh TK; Cera PJ
    Obstet Gynecol; 1983 Jan; 61(1):126-30. PubMed ID: 6823342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The DES story.
    Gunning JE
    Obstet Gynecol Surv; 1976 Nov; 31(11):827-33. PubMed ID: 980278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear-cell adenocarcinoma of the genital tract in young females. Registry report.
    Herbst AL; Kurman RJ; Scully RE; Poskanzer DC
    N Engl J Med; 1972 Dec; 287(25):1259-64. PubMed ID: 4636892
    [No Abstract]   [Full Text] [Related]  

  • 26. In utero diethylstilbestrol exposure: structural and epithelial abnormalities.
    Noller KL
    Cervix Low Female Genital Tract; 1983; 1(2):75-82. PubMed ID: 12266371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal adenosis and diethylstilboestrol.
    Emens M
    Br J Hosp Med; 1984 Jan; 31(1):42-8. PubMed ID: 6697040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE; Robboy SJ; Herbst AL
    Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of DES-exposed women: one physician's approach.
    Scott JW
    J Reprod Med; 1976 Jun; 16(6):285-8. PubMed ID: 957347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stilbestrol child.
    Franklin EW; Dudley AG; Caputo TA
    J Med Assoc Ga; 1974 Feb; 63(2):66-7. PubMed ID: 4130464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
    Melnick S; Cole P; Anderson D; Herbst A
    N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diethylstilbestrol-related clear-cell adenocarcinoma in women with initial examinations demonstrating no malignant disease.
    Kramer MS; Seltzer V; Krumholz B; Talebian F; Tedeschi C; Chen S
    Obstet Gynecol; 1987 Jun; 69(6):868-71. PubMed ID: 3574818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol.
    Camp EA; Coker AL; Troisi R; Robboy SJ; Noller KL; Goodman KJ; Titus-Ernstoff LT; Hatch EE; Herbst AL; Kaufman RH; Adam E
    J Low Genit Tract Dis; 2008 Apr; 12(2):111-7. PubMed ID: 18369304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
    Hall WB; Detterbeck FC; Livasy CA; Fowler WC
    Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adenocarcinoma and adenosis of the vagina. On the histogenesis, diagnosis and therapy of a rare genital neoplasms].
    Maassen V; Lampe B; Untch M; Mikorey S; Hepp H; Kindermann G
    Geburtshilfe Frauenheilkd; 1993 May; 53(5):308-13. PubMed ID: 8514101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed onset of clear cell adenocarcinoma of the vagina in DES-exposed progeny.
    Veridiano NP; Tancer ML; Delke I; Gal D; Giannattasio C
    Obstet Gynecol; 1981 Mar; 57(3):395-8. PubMed ID: 7465156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.